文献速递血液净化与透析

血液透析患者皮肤自发荧光变化趋势与死亡风险的前瞻性研究

Prospective Study of Change in Skin Autofluorescence Over Time and Mortality in People Receiving Hemodialysis.
PubMed 文献 · Kidney Int Rep · 2024-03-26

该前瞻性观察研究纳入120例血液透析患者,随访5年,定期测量皮肤自发荧光(SAF)。中位观察42个月期间49%患者死亡。多变量分析显示,较高基线SAF和SAF上升趋势均为全因死亡的独立预测因素。

要点

  • 较高基线SAF和SAF上升趋势均独立预测血液透析患者全因死亡。
  • SAF趋势的预测风险比基线SAF更高。
  • 监测SAF可能有助于识别高危透析患者。

核心结论

  • 在血液透析人群中,SAF上升趋势和较高基线SAF是全因死亡的独立预测因素。

研究设计与样本

  • 前瞻性观察研究,纳入120例血液透析患者,随访5年。
  • SAF在基线、3、6、9、12和24个月测量,用线性回归计算变化率。

主要发现

  • 平均年龄65±14岁,平均基线SAF为3.4±0.9 AU,中位SAF趋势为每年增加0.1(-0.1至0.4)AU。
  • 中位观察42个月,59例(49%)死亡。
  • 多变量分析中,较高基线SAF的HR为1.45(95%CI 1.08-1.94,P=0.01),SAF上升趋势的HR为2.37(95%CI 1.43-3.93,P<0.001)。

临床怎么用

  • 可考虑将SAF监测用于血液透析患者死亡风险评估。
  • 针对降低或阻止SAF上升的干预策略值得前瞻性研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Elevated skin autofluorescence (SAF), a measure of tissue accumulation of advanced glycation end products (AGEs), is a strong predictor of all-cause and cardiovascular mortality in the hemodialysis population. However, prospective studies investigating the association between changes in SAF over time and mortality are scarce. We therefore aimed to investigate the prognostic value of SAF trend for predicting mortality in a hemodialysis population. METHODS: We enrolled 120 patients on hemodialysis in a 5-year observational, prospective study. SAF was measured at baseline, 3, 6, 9, 12, and 24 months. Rate of change in SAF (i.e., SAF trend) was calculated using linear regression. Time to event was the number of days from baseline to death, kidney transplantation, or March 31, 2022. RESULTS: Mean age, mean baseline SAF, and median SAF trend were 65 ± 14 years, 3.4 ± 0.9 arbitrary units (AU), and an increase of 0.1 (-0.1 to 0.4) AU/yr, respectively. Median observation time was 42 months, during which 59 participants (49%) died. Univariable analysis identified age, history of smoking, lower serum albumin, higher baseline SAF, and increase in SAF as significant predictors of higher mortality. In multivariable analysis, higher baseline SAF (hazard ratio: 1.45; 95% confidence interval: 1.08-1.94; P = 0.01) and increasing SAF trend (2.37 [1.43-3.93]; P < 0.001) were independent predictors of increased mortality. CONCLUSION: An increasing SAF trend and higher baseline SAF were independent predictors of all-cause mortality in this hemodialysis population, suggesting that monitoring of SAF may have clinical utility. Strategies to improve outcomes by reducing or preventing the increase in SAF should now be investigated in prospective studies.

来源:Kidney Int Rep,查看原文。版权归原作者所有。

引用

  1. Viramontes-Hörner D, Selby NM, Taal MW, et al. Prospective Study of Change in Skin Autofluorescence Over Time and Mortality in People Receiving Hemodialysis. Kidney Int Rep. 2024. PMID: 39081750. doi:10.1016/j.ekir.2024.03.020

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。